Verona Pharma (NASDAQ:VRNA)'s stock has reached an unprecedented peak, setting an all-time high at $56.49. This milestone underscores a remarkable period of growth for the $4.49 billion ...
These four Buy-rated stocks are trading under $10 and could offer patient investors enormous returns for 2025 and beyond.
Roth Mkm restated their buy rating on shares of TriSalus Life Sciences (NASDAQ:TLSI – Free Report) in a research report ...
We recently published a list of 10 Unstoppable Stocks to Buy in 2025. In this article, we are going to take a look at where ...
Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...
Fintel reports that on January 23, 2025, Roth MKM initiated coverage of Innventure (NasdaqGM:INV) with a Buy recommendation.
Roth MKM analyst Justin Clare reiterated a Buy rating on American Superconductor (AMSC – Research Report) today and set a price target of ...